Studies related to HDL-C and Policosanol

Comparative Lipid-lowering Effects Of Policosanol And Atorvastatin: A Randomized, Parallel, Double-blind, Placebo-controlled Trial

Effect None
Trial Design Double blind
Trial Length n/a
Number of Subjects 99
Sex n/a
Notes for this study:
Policosanol at 20mg per day was ineffective at lowering plasma lipid markers over a period of 12 weeks when compared to baseline and to placebo in a population of persons with high cholesterol. It showed no further additions when paired with statins

Full details on all 12 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.